UT Health San Antonio | The University of Texas Health Science Center at San Antonio
Category ID
26

UT Health San Antonio scientist discovers stress-triggered pathway behind migraines

A scientist at The University of Texas Health Science Center at San Antonio has discovered a pathway triggered in the brain during stressful situations. Halting this process at an early stage could prevent the domino effect that leads to migraines.

Share This Story

Trailblazing neuroscientist studies cognitive deficits in Duchenne muscular dystrophy

Duchenne muscular dystrophy is the most common form of childhood muscular dystrophy and one of the most severe forms of inherited muscular dystrophy. The x-linked genetic condition causes mutations in the dystrophin gene that leads to progressive muscle weakness.  Typically affecting boys, it occurs in about every 1 in 3,500 to 5,000 male births, with […]

Share This Story

Two UT Health San Antonio scientists awarded V Foundation grants to advance innovative cancer research

This year in the United States, it is projected that more than 2 million people will be diagnosed with cancer. Additionally, more than 600,000 people will die of the disease — an average of nearly 1,680 each day. The V Foundation for Cancer Research was founded in 1993 by ESPN and basketball coach Jim Valvano […]

Share This Story

World-renowned Alzheimer’s researcher receives $300,000 UT System Faculty STARs award

Agustin Ruiz, MD, PhD, professor and director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases’ Biological Core laboratory and the Keith M. and Pat V. Orme Endowed Chair in Alzheimer’s and Neurodegenerative Diseases at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a $300,000 UT System […]

Share This Story

Life, legacy of 2024 Basser Global Prize winner Patrick Sung

World-renowned biochemist and expert on the roles of BRCA1 and BRCA 2 in DNA repair, Patrick Sung, DPhil, director of the Greehey Children’s Cancer Research Institute and associate dean for research at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently recognized as the 2024 recipient of the […]

Share This Story

Dedicating a ‘place of firsts’

Today, The University of Texas Health Science Center at San Antonio proudly dedicated the new $472 million UT Health San Antonio Multispecialty and Research Hospital in front of leaders from The University of Texas System, UT Health San Antonio and Mays Cancer Center, as well as donors, elected officials and other distinguished guests.

Share This Story

Center for Pain Therapeutics and Addiction Research earns first NIH grant

The School of Dentistry earned the first National Institutes of Health grant under its new Center for Pain Therapeutics and Addiction Research, addressing pain in patients with head and neck carcinoma.

Share This Story

$1.2M federal grant awarded to project aiming to increase number of occupational therapists and speech-language pathologists trained to serve children with high-intensity needs

An interprofessional workforce development project led by School of Health Professions faculty and funded by a $1.2 million grant from the Department of Education Office of Special Education Programs aims to address the shortage of highly qualified occupational therapists and speech-language pathologists trained to serve school-age children with high-intensity needs. The five-year grant will support […]

Share This Story

Renowned cancer researcher brings $500,000 UT System Faculty STARs award to UT Health San Antonio

  Simon Gayther, PhD, professor of medicine in the Division of Hematology and Oncology in the Joe R. and Teresa Lozano Long School of Medicine and founding director in the school’s Center for Inherited Oncogenesis at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), received a $500,000 UT System […]

Share This Story

Gene-mutation pathway discovery paves way for targeted blood cancers therapies

Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway of […]

Share This Story

Subscribe to Research